PIN38- COST-EFFECTIVENESS OF LOPINAVIR/RITONAVIR COMPARED TO NELFINAVIR AS FIRST-LINE ANTIRETROVIRAL THERAPY IN TREATMENTNAVE HIV PATIENTS- A MANAGED CARE PERSPECTIVE

May 1, 2003, 00:00 AM
10.1016/S1098-3015(10)64015-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)64015-6/fulltext
Section Title :
Section Order : 216
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64015-6&doi=10.1016/S1098-3015(10)64015-6
HEOR Topics :
Tags :
Regions :